Synthetic Biology (non-pharma)▲
Syngenta and Amoéba Sign Exclusive European Biofungicide Deal
Syngenta Crop Protection AG and Amoéba have announced an exclusive supply and distribution agreement for a next-generation biocontrol fungicide, formulation AXP20, targeting cereal diseases across the European Union, the United Kingdom, Ukraine, and Switzerland. The binding long-term partnership, which converts a November 2025 memorandum of understanding, covers all cereals except corn and aims to control septoria tritici blotch and yellow rust, which together affect an estimated 9 to 12 million hectares annually. First market registrations are expected in the third quarter of 2028, with initial sales in core EU markets by the end of that year for spring 2029 use. The product, based on the lysate of the amoeba Willaertia magna C2c Maky, received EU approval in 2025 and is classified under FRAC Group BM02 with low resistance risk. Amoéba's managing director, Jean-Marc Petat, called the agreement a defining milestone, noting that Syngenta's screening selected AXP20 as the highest performing biofungicide among many biological solutions.
About megatrends
Synthetic Biology (non-pharma) › Agri-Biotech & Microbial Inputs ▲Demand
ALMIB.PA · Demand · Positive Amoéba signs exclusive long-term supply and distribution deal with Syngenta for its AXP20 biofungicide across European cereals
先正达集团股份有限公司 (Syngenta Group Co., Ltd.) · Demand · Positive Syngenta secures exclusive distribution rights to a next-generation biofungicide targeting septoria and yellow rust across 9-12 million hectares